跳至主要内容

Amyloid Goiter: Clinicopathological Assessment of Two Cases and Review of Literature

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53282#.VLx3dcnQrzE

ABSTRACT
Amyloid goiter (AG) is a rare but well-established disease entity that may occur in a number of conditions. In the following article, we will report two cases of AG. Both patients were young males: 28 & 24 years old, presented with rapidly enlarging thyroid gland manifested with pressure effects (dyspnea and hoarseness of voice). Provisional clinical diagnosis was malignant thyroid neoplasm. One of the patients was markedly hypothyroid while the other was euthyroid. Histopathological evaluation revealed extracellular deposition of deep pink homogenous material that was confirmed as amyloid with congo red. Patient in case 1 was primary localized AG while patient in case 2 was systemic amyloidosis secondary to interstitial pulmonary fibrosis (IPF) that was first manifested by AG. The main aims of the article were to describe histopathological features of amyloidosis of the thyroid gland and to raise awareness of AG to be included in the differential diagnosis in patients presented with rapidly enlarging goiter with mass effects.
 
Cite this paper
Mohammed, R. , Yassin, E. , Radwan, M. , Ahmed, B. , Ettouny, L. and Abozied, A. (2015) Amyloid Goiter: Clinicopathological Assessment of Two Cases and Review of Literature. Open Journal of Pathology, 5, 20-27. doi: 10.4236/ojpathology.2015.51004.
 
References
[1]Villa, F., Dionigi, G., Tanda, M.L., Rovera, F. and Boni, L. (2008) Amyloid Goiter. International Journal of Surgery, 6, S16-S18. http://dx.doi.org/10.1016/j.ijsu.2008.12.025
 
[2]Duzgun, N., Morris, Y., Yildiz, H.I., Ozturk, S., Ayva, S.K., Ensari, A., et al. (2003) Amyloid Goiter in Juvenile Onset Rheumatoid Arthritis. Scandinavian Journal of Rheumatology, 32, 253-254. http://dx.doi.org/10.1080/03009740310003776
 
[3]Hamed, G., Heffess, C.S., Shmookler, B.M. and Wenig, B.M. (1995) Amyloid Goiter. A Clinicopathologic Study of 14 Cases and Review of the Literature. American Journal of Clinical Pathology, 104, 306-312.
 
[4]Alvarez-Sala, R., Prados, C., Sastre Marcos, J., Garcia Rio, F., Vicandi, B., et al. (1995) Amyloid Goitre and Hypothyroidism Secondary to Cystic Fibrosis. Postgraduate Medical Journal, 71, 307-308. http://dx.doi.org/10.1136/pgmj.71.835.307
 
[5]Cohan, P., Hirschowitz, S., Rao, J.Y., Tanavoli, S. and Van Herle, A.J. (2000) Amyloid Goiter in a Case of Systemic Amyloidosis Secondary to Ankylosing Spondylitis. Journal of Endocrinological Investigation, 23, 762-764.
 
[6]Habu, S., Watanobe, H., Kimura, K. and Suda, T. (1999) A Case of Amyloid Goiter Secondary to Crohn’s Disease. Endocrine Journal, 46, 179-182. http://dx.doi.org/10.1507/endocrj.46.179
 
[7]Chraibi, A., Msyah, L., Laaribi, O., Marrakchi, A. and Hafidi, A. (2009) Amyloid Goiter: First Sign of Systemic Amyloidosis. Annales d’Endocrinologie, 70, 80-82. http://dx.doi.org/10.1016 /j.ando.2007.10.002
 
[8]D’Antonio, A., Franco, R., Sparano, L., Terzi, G. and Pettinato, G. (2000) Amyloid Goiter: The First Evidence in Secondary Amyloidosis. Report of Five Cases and Review of Literature. Advances in Clinical Pathology, 4, 99-106.
 
[9]Yildiz, L., Kefeli, M., Kose, B. and Baris, S. (2009) Amyloid Goiter: Two Cases and a Review of the Literature. Annals of Saudi Medicine, 29, 138-141. http://dx.doi.org/10.4103/0256-4947.51808
 
[10]Bell, G.O. and Mena, B.A. (1963) Amyloid Goiter Associated with the Nephrotic Syndrome. Medical Clinics of North America, 47, 385-389.
 
[11]Danovitch, G.M., Le Roith, D., Sobel, R., Sikuler, E. and Straus, R. (1979) Amyloid Goitre in Familial Mediterranean Fever. Clinical Endocrinology, 11, 595-601. http://dx.doi.org/10.1111/j.1365-2265.1979.tb03113.x
 
[12]Kanoh, T., Shimada, H., Uchino, H. and Matsumura, K. (1989) Amyloid Goiter with Hypothyroidism. Archives of Pathology & Laboratory Medicine, 113, 542-544.
 
[13]Villamil, C.F., Massimi, G., D’Avella, J. and Cole, S.R. (2000) Amyloid Goiter with Parathyroid Involvement: A Case Report and Review of the Literature. Archives of Pathology & Laboratory Medicine, 124, 281-283.
 
[14]Siddiqui, M.A., Gertz, M. and Dean, D. (2007) Amyloid Goiter as a Manifestation of Primary Systemic Amyloidosis. Thyroid, 17, 77-80. http://dx.doi.org/10.1089/thy.2006.0045
 
[15]Ozdemir, B.H., Akman, B. and Ozdemir, F.N. (2001) Amyloid Goiter in Familial Mediterranean Fever (FMF): A Clinicopathologic Study of 10 Cases. Renal Failure, 23, 659-667. http://dx.doi.org/10.1081/JDI-100107362
 
[16]Srivastava, A., Baxi, M., Yadav, S., Agarwal, A., Gupta, R.K., Misra, S.K. and Mithal, A. (2001) Juvenile Rheumatoid Arthritis with Amyloid Goiter: Report of a Case with Review of the Literature. Endocrine Pathology, 12, 437-441. http://dx.doi.org/10.1385/EP:12:4:437
 
[17]Arafa, S., Sakr, M., Khedr, M., Khalil, R., Abdel-Baset, H., Moussa, M. and El-Sharaky, M. (2001) Amyloid Goiter: A Diagnostic and Therapeutic Challenge. Egyptian Journal of Surgery, 20, 561-567.
 
[18]Duhra, P. and Cassar, J. (1990) Thyroid Function Tests in Amyloid Goitre. Postgraduate Medical Journal, 66, 304-306. http://dx.doi.org/10.1136/pgmj.66.774.304
 
[19]Ozdemir, D., Dagdelen, S., Erbas, T., Sokmensuer, C., Erbas, B. and Cila, A. (2011) Amyloid Goiter and Hypopituitarism in a Patient with Systemic Amyloidosis. Amyloid, 18, 32-34. http://dx.doi.org/10.3109/13506129.2010.545961
 
[20]Kimura, H., Yamashita, S., Ashizawa, K., Yokoyama, N. and Nagataki, S. (1997) Thyroid Dysfunction in Patients with Amyloid Goitre. Clinical Endocrinology, 46, 769-774. http://dx.doi.org/10.1046/j.1365-2265.1997.1841000.x
 
[21]Schroder, S. and Bocker, W. (1985) Lipomatous Lesions of the Thyroid Gland: A Review. Applied Pathology, 3, 140-149.
 
[22]Kumar, V., Cotran, R.S. and Robbins, S. (1997) Amyloidosis. In: Basic Pathology, 6th Edition, W.B. Saunders Company, Philadelphia, 126-130.
 
[23]Kisilevsky, R. and Axelrad, M. (1976) The Pathogenesis of Amyloid Deposition: A New Hypothesis. Medical Hypotheses, 2, 233-237. http://dx.doi.org/10.1016/S0306-9877(76)80002-3
 
[24]Husby, G. (1980) A Chemical Classification of Amyloid: Correlation with Different Clinical Types of Amyloidosis. Scandinavian Journal of Rheumatology, 9, 60-64. http://dx.doi.org/10.3109 /03009748009098131
 
[25]Sharma, O.P. (2001) Unusual Systemic Disorders Associated with Interstitial Lung Disease. Current Opinion in Pulmonary Medicine, 7, 291-294. http://dx.doi.org/10.1097/00063198-200109000-00007
 
[26]DiBartola, S.P. and Benson, M.D. (1989) The Pathogenesis of Reactive Systemic Amyloidosis. Journal of Veterinary Internal Medicine, 3, 31-41. http://dx.doi.org/10.1111/j.1939-1676.1989.tb00326.x
 
[27]Gertz, M.A. and Kyle, R.A. (1991) Secondary Systemic Amyloidosis: Response and Survival in 64 Patients. Medicine, 70, 246-256. http://dx.doi.org/10.1097/00005792-199107000-00002
 
[28]Migita, K., Yamasaki, S., Shibatomi, K., Ida, H., Kita, M., Kawakami, A. and Eguchi, K. (2001) Impaired Degradation of Serum Amyloid A (SAA) Protein by Cytokine-Stimulated Monocytes. Clinical & Experimental Immunology, 123, 408-411. http://dx.doi.org/10.1046/j.1365-2249.2001.01472.x                                            eww150119lx
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文